Drug Discovery and Drug delivery system

Regulatory Considerations in Drug Development

The "Regulatory Considerations in Drug Development" track at Drug Delivery 2024 conference invites abstract submissions focusing on navigating the complex regulatory landscape in pharmaceutical development. Researchers are encouraged to present insights, strategies, and case studies addressing regulatory challenges throughout the drug development lifecycle.

Attendees can expect a comprehensive examination of regulatory requirements, guidelines, and best practices governing preclinical studies, clinical trials, and marketing approval processes. Presentations will delve into key considerations for successful regulatory submissions, including data integrity, quality assurance, and compliance with international standards.

Moreover, discussions will cover emerging trends and updates in regulatory frameworks, including expedited pathways for breakthrough therapies, orphan drug designations, and post-marketing surveillance requirements. Attendees will gain insights into regulatory strategies for innovative drug delivery technologies, combination therapies, and personalized medicine approaches.